Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Superimposing candesartan onto ACE inhibition slows renal function decline in nondiabetic chronic kidney disease

Nature Clinical Practice Nephrology volume 3, pages 8–9 (2007)Cite this article

boxed-textKanno Y et al. (2006) Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors. Clin J Am Soc Nephrol 1: 730–737

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Ihara M et al. (1999) Increased chymase-dependent angiotensin II formation in human atherosclerotic aorta. Hypertension 33: 1399–1405

    Article  CAS  Google Scholar 

  2. Yagi S et al. (2004) Combined treatment with an AT1 receptor blocker and angiotensin converting enzyme inhibitor has an additive effect on inhibiting neointima formation via improvement of nitric oxide production and suppression of oxidative stress. Hypertens Res 27: 129–135

    Article  CAS  Google Scholar 

  3. Andersen NH and Mogensen CE (2004) Dual blockade of the renin angiotensin system in diabetic and nondiabetic kidney disease. Curr Hypertens Rep 6: 369–376

    Article  Google Scholar 

  4. Nakao N and Kimura G (2003) Submaximal dose of trandolapril in the COOPERATE trial? Kidney Int 64: 1921–1922

    Article  Google Scholar 

  5. Andersen NH et al. (2005) Long-term dual blockade with candesartan and lisinopril in hypertensive patients with diabetes: the CALM II study. Diabetes Care 28: 273–277

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloë Harman, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Cardiology, Randers County Hospital, Randers, DK-8900 Denmark holmark@iekf.au.dk

Authors and Affiliations

  1. NH Andersen is Specialist Registrar in the Department of Cardiology at Randers County Hospital, Randers, Denmark.,

    Niels H Andersen

Authors
  1. Niels H Andersen
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Andersen, N. Superimposing candesartan onto ACE inhibition slows renal function decline in nondiabetic chronic kidney disease. Nat Rev Nephrol 3, 8–9 (2007). https://doi.org/10.1038/ncpneph0348

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0348

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing